Fertility preservation options Standard strategy Ovarian stimulation required Invasive procedure required Male partner required Risk of malignant cells contamination Delay in cancer treatment Available in all centers Oocyte cryopreservation +…
Diagnosed at or before 45 years of age Having 2 breast primaries with one being diagnosed ≤50 years of age Diagnosed ≤50 years with at least 1 close relative with…
© Springer International Publishing Switzerland 2015Nicoletta Biglia and Fedro Alessandro Peccatori (eds.)Breast Cancer, Fertility Preservation and Reproduction10.1007/978-3-319-17278-1_5 5. Breast Cancer During Pregnancy Giovanni Codacci-Pisanelli1, 2 , Giovanna Scarfone3 , Lino Del Pup4 , Eleonora Zaccarelli2 and Fedro A. Peccatori1 (1) Fertility and Procreation Unit, European…
Age Annual incidence <20 0.1/100,000 20–24 1.4/100,000 25–29 8.1/100,000 30–34 24.8/100,000 35–39 58.4/100,000 40–44 116.1/100,000 Modified by Pagani and Goldhirsh (2000) [6] Young age, even after adjustment for socio-demographic and…
Time to subsequent pregnancy (months) Beta coefficient P value Hazard ratio (95 % CI) <6 0.79 0.579 2.20 (0.14–35.42) 6–24 −0.80 0.135 0.45 (0.16–1.28) >24 −0.74 0.009 0.48 (0.27–0.83) (Each…
© Springer International Publishing Switzerland 2015Nicoletta Biglia and Fedro Alessandro Peccatori (eds.)Breast Cancer, Fertility Preservation and Reproduction10.1007/978-3-319-17278-1_1 1. Epidemiology of Breast Cancer in Young Women Fabio Parazzini1 , Antonella Villa1 , Giampiero Polverino1 , Stefania Noli1 and Giovanna Scarfone1 (1) Dipartimento di Scienze…
Trial Patient population characteristics Study design Median follow-up DFS (HR, 95 % CI) OS (HR, 95 % CI) ABCSG-12 [94, 96] 1,803 premenopausal women. No adjuvant chemotherapy Median age 45…
